$4.00 -0.11 (-2.68%)
11/25/2009 4:00 PM

Santarus, Inc. (SNTS)

CAPS Rating: 3 out of 5

A pharmaceutical company focused on acquiring, developing and commercializing proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.

Featured Broker Partners